Exelixis (EXEL) Divestments (2010 - 2015)
Exelixis (EXEL) posted quarterly Divestments of $95000.0 for Q1 2015, down 88.12% quarter-over-quarter from $800000.0 in Q3 2014.
Exelixis (EXEL) Divestments (2010 - 2015) Analysis & Trends
Exelixis' Divestments history runs 3 years deep, the most recent figure standing at $95000.0 for Q1 2015.
- In Q1 2015, Divestments changed N/A year-over-year to $95000.0; the TTM figure through Jun 2015 stood at $895000.0 (changed N/A YoY), while the FY2014 annual figure was $838000.0, changed N/A from the prior year.
- Divestments for Q1 2015 stood at $95000.0, down from $800000.0 in the prior quarter.
- The five-year high for Divestments was $800000.0 in Q3 2014, with the low at $95000.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 9.82 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -13.21 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Exelixis | 12.75 Bn | 11.91 Bn | 608.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 95,000.00 |
| Sep 30, 2014 | 800,000.00 |
| Dec 31, 2010 | 400,000.00 |